← Leaderboards
Jacob Yount
Ohio State University
$9,023,802
Attributed
$13,268,120
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,268,120 · 10
By mechanism
R01$11,015,453 · 4
R21$1,252,905 · 3
R00$493,543 · 1
R56$366,224 · 1
K99$139,995 · 1
Top collaborators
- Federica Accornero4 shared
- Chuanxi Cai4 shared
- Jianjie Ma4 shared
- Amal O Amer3 shared
- Murugesan Rajaram2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Mark R Parthun$8,798,119
- Linda J. Saif$10,776,838
- Murugesan Rajaram$3,614,718
Others in their field
Top investigators on “Interferons”
- Norman Wolmark · Nsabp Foundation, Inc.$62,740,119
- Kent J. Weinhold · Duke University$39,902,311
- Michael J Gale · University Of Texas Sw Med Ctr/Dallas$39,525,737
- Charles M. Rice · Rockefeller University$34,398,649
- Luis J. Montaner · Wistar Institute$32,339,250
- Lionel B Ivashkiv · Hospital For Special Surgery$29,564,114
Research focus
InterferonsVirus DiseasesInfectionProteinsVirusPreventCellsIntegral Membrane ProteinKnockout MiceGeneticViralInfluenzavirusMouse ModelPathologyPredispositionInfluenzaInflammationTissuesAntiviral AgentsHeartImmunityCardiacReportingVirus Replication
Grant awards (32)
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections$716,669
R01 · FY2025 · HL · contact PI
Protein therapy to treat virus induced cardiopulmonary injury$655,228
R01 · FY2025 · HL
Mechanisms of innate resistance to virus infections$438,704
R01 · FY2025 · AI · contact PI
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections$702,336
R01 · FY2024 · HL · contact PI
Protein therapy to treat virus induced cardiopulmonary injury$642,124
R01 · FY2024 · HL
Mechanisms of innate resistance to virus infections$446,776
R01 · FY2024 · AI · contact PI
Mechanisms of innate resistance to virus infections$85,543
R01 · FY2024 · AI · contact PI
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections$749,419
R01 · FY2023 · HL · contact PI
Protein therapy to treat virus induced cardiopulmonary injury$655,228
R01 · FY2023 · HL
Mechanistic characterization of a new master regulator of cardiac virus infections$581,395
R01 · FY2023 · HL · contact PI
Mechanisms of innate resistance to virus infections$460,087
R01 · FY2023 · AI · contact PI
Mechanisms of innate resistance to virus infections$43,560
R01 · FY2023 · AI · contact PI
Protein therapy to treat virus induced cardiopulmonary injury$732,174
R01 · FY2022 · HL
Mechanistic characterization of a new master regulator of cardiac virus infections$581,395
R01 · FY2022 · HL
Mechanisms of innate resistance to virus infections$471,166
R01 · FY2022 · AI · contact PI
Mechanistic characterization of a new master regulator of cardiac virus infections$581,395
R01 · FY2021 · HL
Mechanisms of innate resistance to virus infections$377,709
R01 · FY2021 · AI · contact PI
Establishing a relevant mouse model with susceptibility to non-adapted influenza viruses for vaccine challenge studies$223,680
R21 · FY2021 · AI · contact PI
Mechanistic characterization of a new master regulator of cardiac virus infections$581,395
R01 · FY2020 · HL
Mechanisms of innate resistance to virus infections$378,405
R01 · FY2020 · AI · contact PI
Inhibition of cell-to-cell fusion by interferon-induced proteins$234,000
R21 · FY2020 · AI · contact PI
Mechanisms of Cardioprotection by the Innate Immune System During Influenza Virus Infections$187,776
R21 · FY2020 · AI
Establishing a relevant mouse model with susceptibility to non-adapted influenza viruses for vaccine challenge studies$185,264
R21 · FY2020 · AI · contact PI
Mechanisms of innate resistance to virus infections$379,061
R01 · FY2019 · AI · contact PI
Mechanisms of Cardioprotection by the Innate Immune System During Influenza Virus Infections$227,185
R21 · FY2019 · AI
Inhibition of cell-to-cell fusion by interferon-induced proteins$195,000
R21 · FY2019 · AI · contact PI
Mechanisms of innate resistance to virus infections$378,715
R01 · FY2018 · AI · contact PI
Mechanisms of innate resistance to virus infections$376,969
R01 · FY2017 · AI · contact PI
Molecular Control of IFITM3 in Restricting Influenza Virus Infection$366,224
R56 · FY2015 · AI · contact PI
Mechanistic analysis of a posttranslationally modified innate antiviral effector$244,543
R00 · FY2014 · AI · contact PI
Mechanistic analysis of a posttranslationally modified innate antiviral effector$249,000
R00 · FY2013 · AI · contact PI
Mechanistic analysis of a posttranslationally modified innate antiviral effector$139,995
K99 · FY2011 · AI · contact PI